Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente SCHIZOPHRENIA RESEARCH

Tipo Año Título Fuente
Artículo2024A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohortSCHIZOPHRENIA RESEARCH
Artículo2024Anthropometry in antipsychotic-naïve first-episode psychosis patients: an exploratory approach to the role of environmental early life events in two independent samplesSCHIZOPHRENIA RESEARCH
Corrección2024Corrigendum to “Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study” (Schizophrenia Research (2023) 255 (173–181), (S0920996423001147), (10.1016/j.schres.2023.03.020))SCHIZOPHRENIA RESEARCH
Artículo2024Cortical volume abnormalities in schizophrenia: correlations with symptoms and cognitive impairmentSCHIZOPHRENIA RESEARCH
Artículo2024Inflammatory blood cells and ratios at remission for psychosis relapse prediction: a three-year follow-up of a cohort of first episodes of schizophreniaSCHIZOPHRENIA RESEARCH
Artículo2023Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: evidence from an international prospective cohort studySCHIZOPHRENIA RESEARCH
Artículo2023Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: retrospective observational population-base studySCHIZOPHRENIA RESEARCH
Artículo2023Intelligence quotient changes over 10 years: diversity of cognitive profiles in first episode of psychosis and healthy controlsSCHIZOPHRENIA RESEARCH
Artículo2023Lifestyle intervention based on exercise and behavioural counselling and its effect on physical and psychological health in outpatients with schizophrenia spectrum disorders. An exploratory, pragmatic randomized clinical trialSCHIZOPHRENIA RESEARCH
Letter2022A proxy measure of premorbid adjustment in psychosis for large-scale epidemiological studies and electronic health record-based research.SCHIZOPHRENIA RESEARCH
Artículo2022Clinical predictors of antipsychotic treatment resistance: development and internal validation of a prognostic prediction model by the STRATA-G consortiumSCHIZOPHRENIA RESEARCH
Artículo2022Elevated risk of liver steatosis in first-episode psychosis patients: Results from a 3-year prospective studySCHIZOPHRENIA RESEARCH
Artículo2022Longitudinal effects of cannabis use on attentional processes in patients with first episode of psychosisSCHIZOPHRENIA RESEARCH
Artículo2022Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: Baseline results from the PAFIP cohortSCHIZOPHRENIA RESEARCH
Letter2022Reduced glomerular filter rate in antipsychotic-naïve patients with first-episode psychosisSCHIZOPHRENIA RESEARCH
Artículo2022The network structure of cognitive deficits in first episode psychosis patientsSCHIZOPHRENIA RESEARCH
Letter2021Long-term clinical and functional outcome after antipsychotic discontinuation in early phases of non-affective psychosis: Results from the PAFIP-10 cohortSCHIZOPHRENIA RESEARCH
Letter2021Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish populationSCHIZOPHRENIA RESEARCH
Artículo2021Neurobiological underpinnings of cognitive subtypes in psychoses: A cross-diagnostic cluster analysisSCHIZOPHRENIA RESEARCH
Letter2021The role of antipsychotics against COVID-19: a topic for debateSCHIZOPHRENIA RESEARCH
Letter2020Abnormal self-experiences related to a hypersynchronic brain state in schizophreniaSCHIZOPHRENIA RESEARCH
Artículo2020Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up studySCHIZOPHRENIA RESEARCH
Revisión2020Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysisSCHIZOPHRENIA RESEARCH
Artículo2020Predictors of weight acquisition induced by antipsychotic treatment and its relationship with age in a sample of first episode non-affective psychosis patients: A three-year follow-up studySCHIZOPHRENIA RESEARCH
Letter2019Incidence of psychotic disorders and its association with methodological issues. A systematic review and meta-analysesSCHIZOPHRENIA RESEARCH
Artículo2019Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: Effects of previous suicide attempts and depressionSCHIZOPHRENIA RESEARCH
Artículo2019Patterns of recovery course in early intervention for FIRST episode non-affective psychosis patients: The role of timingSCHIZOPHRENIA RESEARCH
Artículo2018Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-upSCHIZOPHRENIA RESEARCH
Artículo2018Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized studySCHIZOPHRENIA RESEARCH
Letter2018Differences in the impairment of insight between deficit syndrome and non-deficit syndrome patients with first-episode schizophreniaSCHIZOPHRENIA RESEARCH
Artículo2018Premorbid IQ subgroups in first episode non affective psychosis patients: Long-term sex differences in function and neurocognitionSCHIZOPHRENIA RESEARCH
Artículo2018Relationship between objectively measured sedentary behavior and health outcomes in schizophrenia patients: The PsychiActive projectSCHIZOPHRENIA RESEARCH
Artículo2018Sedentary behaviour, physical activity, cardiorespiratory fitness and cardiometabolic risk in psychosis: The PsychiActive projectSCHIZOPHRENIA RESEARCH
Artículo2018Targeting recovery in first episode psychosis: The importance of neurocognition and premorbid adjustment in a 3-year longitudinal studySCHIZOPHRENIA RESEARCH
Artículo2018Tobacco smoking and its association with cognition in first episode psychosis patientsSCHIZOPHRENIA RESEARCH
Artículo2017Disability multilevel modelling in first episodes of psychosis at 3-year follow-upSCHIZOPHRENIA RESEARCH
Artículo2017Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1 year studySCHIZOPHRENIA RESEARCH
Letter2017Validation of schizophrenia gene expression profile in a preclinical model of maternal infection during pregnancySCHIZOPHRENIA RESEARCH
Artículo2015A dimensional comparison between delusional disorder, schizophrenia and schizoaffective disorderSCHIZOPHRENIA RESEARCH
Artículo2015Greymatter volume differences in non-affective psychosis and the effects of age of onset on grey matter volumes: A voxelwise studySCHIZOPHRENIA RESEARCH
Artículo2014Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosisSCHIZOPHRENIA RESEARCH
Letter2014Genetic study of NRXN1 beta variants in Spanish patients with schizophreniaSCHIZOPHRENIA RESEARCH
Artículo2014Lack of insight 3 years after first-episode psychosis: An unchangeable illness trait determined from first presentation?SCHIZOPHRENIA RESEARCH
Artículo2013Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trialSCHIZOPHRENIA RESEARCH
Artículo2013Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up studySCHIZOPHRENIA RESEARCH
Artículo2012Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapineSCHIZOPHRENIA RESEARCH
Artículo2012Utility of the World Health Organization Disability Assessment Schedule II in schizophreniaSCHIZOPHRENIA RESEARCH
Artículo2011Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: A comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP)SCHIZOPHRENIA RESEARCH
Artículo2011Jumping to conclusions in psychosis: A faulty appraisalSCHIZOPHRENIA RESEARCH
Artículo2011Using structural equations to test for a direct effect of some antipsychotics on triglyceride levels in drug-naive first-episode psychosis patientsSCHIZOPHRENIA RESEARCH
Artículo2010Cannabis use and cognitive functioning in first-episode schizophrenia patientsSCHIZOPHRENIA RESEARCH
Artículo2010First-episode schizophrenia patients neuropsychologically within the normal limits: Evidence of deterioration in speed of processingSCHIZOPHRENIA RESEARCH
Ponencia2010LONG ACTING ANTIPSYCHOTIC; ATYPICAL VERSUS CONVENTIONAL 48 MONTHS OF FOLLOW-UPSCHIZOPHRENIA RESEARCH
Artículo2010Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S)SCHIZOPHRENIA RESEARCH
Artículo2010Possible effects of some antipsychotic drugs on C-reactive protein in a drug-naive psychotic sampleSCHIZOPHRENIA RESEARCH
Artículo2010Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trialSCHIZOPHRENIA RESEARCH
Artículo2009Fewer neurological soft signs among first episode psychosis patients with heavy cannabis useSCHIZOPHRENIA RESEARCH
Artículo2009Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naive populationSCHIZOPHRENIA RESEARCH
Artículo2009Specific brain structural abnormalities in first-episode schizophrenia. A comparative study with patients with schizophreniform disorder, non-schizophrenic non-affective psychoses and healthy volunteersSCHIZOPHRENIA RESEARCH
Artículo20081-year follow-up study of cognitive function in first-episode non-affective psychosisSCHIZOPHRENIA RESEARCH
Artículo2008Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosisSCHIZOPHRENIA RESEARCH
Artículo2008Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophreniaSCHIZOPHRENIA RESEARCH
Artículo2008Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: Findings of a randomized clinical trial in a drug-naive populationSCHIZOPHRENIA RESEARCH
Artículo2007Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophreniaSCHIZOPHRENIA RESEARCH
Corrección2007Prefrontal cognitive functions in stabilized first-episode patients with schizophrenia spectrum disorders: A dissociation between dorsolateral and orbitofrontal functioning (vol 77, pg 279, 2005)SCHIZOPHRENIA RESEARCH
Artículo2007The child and adolescent first-episode psychosis study (CAFEPS): Design and baseline resultsSCHIZOPHRENIA RESEARCH
Artículo2005Prefrontal cognitive functions in stabilized first-episode patients with schizophrenia spectrum disorders: A dissociation between dorsolateral and orbitofrontal functioningSCHIZOPHRENIA RESEARCH
Artículo2003Morphology of the lateral superior temporal gyrus in neuroleptic naive patients with schizophrenia: relationship to symptomsSCHIZOPHRENIA RESEARCH
Corrección2001Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients (vol 46, pg 35, 2000)SCHIZOPHRENIA RESEARCH
Artículo2001Performance on the visual search analog of latent inhibition is modulated by an interaction between schizotypy and genderSCHIZOPHRENIA RESEARCH
Artículo2001Sex differences in the absence of massa intermedia in patients with schizophrenia versus healthy controlsSCHIZOPHRENIA RESEARCH
Artículo2000Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patientsSCHIZOPHRENIA RESEARCH